{
 "name": "葡萄王",
 "slug": "tw-1707",
 "aliases": [
  "葡萄王生技股份有限公司",
  "GKB",
  "1707"
 ],
 "ticker": "1707",
 "industry": "生技醫療業",
 "website": "http://www.grapeking.com.tw",
 "summary": "葡萄王（1707）是上市的生技醫療類股公司，1971 年成立，1982 年上市。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "葡萄王生技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "英文簡稱",
   "value": "GKB",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "掛牌市場",
   "value": "臺灣證券交易所上市",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "上市日期",
   "value": "1982-12-20",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "成立日期",
   "value": "1971-04-01",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "董事長",
   "value": "曾盛麟",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "總經理",
   "value": "曾盛麟",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "實收資本額",
   "value": 1481373730,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "勤業眾信聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "公司網址",
   "value": "http://www.grapeking.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 726307,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": -7.92,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": -5.64,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "管線：GKAC（樟芝植物新藥）",
   "value": "非酒精性脂肪肝｜美國FDA准予第二期人體臨床試驗；預計2026Q4開始收案｜美國IND（試驗執行地點未逐一揭露）",
   "unit": "",
   "as_of": "2026-09-17",
   "source": "https://www.grapeking.com.tw/investor/conference/download/file1/xV0DbaMeb3KR/2026.pdf",
   "note": "IND准予進行試驗不是NDA或上市許可；截至法說日尚未宣稱已開始收案。"
  },
  {
   "claim": "催化劑：GKAC",
   "value": "第二期人體臨床試驗開始收案｜2026Q4（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-17",
   "source": "https://www.grapeking.com.tw/investor/conference/download/file1/xV0DbaMeb3KR/2026.pdf",
   "note": "公司規劃3年完成二期；3年未精確錨定完成季度且超過本次18個月窗口，不另建完成催化劑。"
  },
  {
   "claim": "管線：GKK1（Lactobacillus plantarum）",
   "value": "運動相關疲勞與運動表現之研究用途｜營養補充品人體試驗已完成｜台灣",
   "unit": "",
   "as_of": "2025-03-26",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06893549",
   "note": "NCT06893549；以最新登錄確認COMPLETED；食品研究，非核准治療適應症或藥物Phase。GKK1之lead sponsor為國立體育大學、葡萄王為collaborator；其餘依登錄為Grape King Bio Ltd.。"
  },
  {
   "claim": "管線：LUA益生菌",
   "value": "高尿酸與痛風之研究用途｜營養補充品人體試驗已完成｜台灣",
   "unit": "",
   "as_of": "2026-06-22",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06969469",
   "note": "NCT06969469；以最新登錄確認COMPLETED；食品研究，非核准治療適應症或藥物Phase。GKK1之lead sponsor為國立體育大學、葡萄王為collaborator；其餘依登錄為Grape King Bio Ltd.。"
  },
  {
   "claim": "管線：Lactobacillus spp.益生菌（疫苗免疫原性試驗）",
   "value": "COVID-19疫苗接種後免疫反應之研究用途｜營養補充品人體試驗已完成｜台灣",
   "unit": "",
   "as_of": "2026-06-03",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT07610512",
   "note": "NCT07610512；以最新登錄確認COMPLETED；食品研究，非核准治療適應症或藥物Phase。GKK1之lead sponsor為國立體育大學、葡萄王為collaborator；其餘依登錄為Grape King Bio Ltd.。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-23",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-1707.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}